Jay K Trautman - Net Worth and Insider Trading

Jay K Trautman Net Worth

The estimated net worth of Jay K Trautman is at least $160,426 dollars as of 2024-09-21. Jay K Trautman is the VP, Discovery Research of Cytokinetics Inc and owns about 2,983 shares of Cytokinetics Inc (CYTK) stock worth over $160,426. Details can be seen in Jay K Trautman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jay K Trautman has not made any transactions after 2007-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jay K Trautman

To

Jay K Trautman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jay K Trautman owns 1 companies in total, including Cytokinetics Inc (CYTK) .

Click here to see the complete history of Jay K Trautman’s form 4 insider trades.

Insider Ownership Summary of Jay K Trautman

Ticker Comapny Transaction Date Type of Owner
CYTK Cytokinetics Inc 2007-05-10 VP & Technology

Jay K Trautman Latest Holdings Summary

Jay K Trautman currently owns a total of 1 stock. Jay K Trautman owns 2,983 shares of Cytokinetics Inc (CYTK) as of May 10, 2007, with a value of $160,426.

Latest Holdings of Jay K Trautman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYTK Cytokinetics Inc 2007-05-10 2,983 53.78 160,426

Holding Weightings of Jay K Trautman


Jay K Trautman Form 4 Trading Tracker

According to the SEC Form 4 filings, Jay K Trautman has made a total of 0 transactions in Cytokinetics Inc (CYTK) over the past 5 years. The most-recent trade in Cytokinetics Inc is the sale of 250 shares on May 10, 2007, which brought Jay K Trautman around $10,515.

Insider Trading History of Jay K Trautman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jay K Trautman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jay K Trautman Ownership Network

Ownership Network List of Jay K Trautman

No Data

Ownership Network Relation of Jay K Trautman

Insider Network Chart

Jay K Trautman Owned Company Details

What does Cytokinetics Inc do?

Who are the key executives at Cytokinetics Inc?

Jay K Trautman is the VP & Technology of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .

Cytokinetics Inc (CYTK) Insider Trades Summary

Over the past 18 months, Jay K Trautman made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 373,500 shares made by Robert I Blum , a net sale of 183,194 shares made by Fady Ibraham Malik , and a net sale of 40,000 shares made by B Lynne Parshall .

In summary, during the past 3 months, insiders sold 137,437 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 137,437 shares. During the past 18 months, 658,744 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 658,744 shares.

Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cytokinetics Inc Insider Transactions

No Available Data

Jay K Trautman Mailing Address

Above is the net worth, insider trading, and ownership report for Jay K Trautman. You might contact Jay K Trautman via mailing address: 280 East Grand Avenue, South San Francisco Ca 94080.

Discussions on Jay K Trautman

No discussions yet.